Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL.

Autor: Lyon AR; National Heart and Lung Institute, Imperial College London, London, UK. a.lyon@imperial.ac.uk.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK. a.lyon@imperial.ac.uk., Babalis D; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Morley-Smith AC; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Hedger M; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Suarez Barrientos A; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Foldes G; National Heart and Lung Institute, Imperial College London, London, UK., Couch LS; National Heart and Lung Institute, Imperial College London, London, UK., Chowdhury RA; National Heart and Lung Institute, Imperial College London, London, UK., Tzortzis KN; National Heart and Lung Institute, Imperial College London, London, UK., Peters NS; National Heart and Lung Institute, Imperial College London, London, UK., Rog-Zielinska EA; National Heart and Lung Institute, Imperial College London, London, UK.; Institute for Experimental Cardiovascular Medicine, University Heart Center, Medical Center, University of Freiburg, Freiburg, Germany., Yang HY; National Heart and Lung Institute, Imperial College London, London, UK., Welch S; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Bowles CT; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Rahman Haley S; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Bell AR; Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Trust, Freiburg, Germany., Rice A; Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Trust, Freiburg, Germany., Sasikaran T; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Johnson NA; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Falaschetti E; Imperial Clinical Trials Unit (ICTU), School of Public Health, Imperial College London, London, UK., Parameshwar J; Royal Papworth Hospital NHS Trust, Cambridge, UK., Lewis C; Royal Papworth Hospital NHS Trust, Cambridge, UK., Tsui S; Royal Papworth Hospital NHS Trust, Cambridge, UK., Simon A; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Pepper J; National Heart and Lung Institute, Imperial College London, London, UK.; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Rudy JJ; Celladon Corporation, San Diego, CA, USA., Zsebo KM; Celladon Corporation, San Diego, CA, USA., Macleod KT; National Heart and Lung Institute, Imperial College London, London, UK., Terracciano CM; National Heart and Lung Institute, Imperial College London, London, UK., Hajjar RJ; Phospholamban Foundation, Amsterdam, Netherlands., Banner N; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton and Harefield Hospitals NHS Trust, London, UK., Harding SE; National Heart and Lung Institute, Imperial College London, London, UK.

Publikováno v: Gene therapy [Gene Ther] 2020 Dec; Vol. 27 (12), pp. 579-590. Date of Electronic Publication: 2020 Jul 15.

Stressing the Importance of Cardiac Assessment in Pheochromocytoma.

Autor: Morley-Smith AC; National Institute for Health Research Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom; National Heart & Lung Institute, Imperial College London, London, United Kingdom., Lyon AR; National Institute for Health Research Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom; National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: a.lyon@imperial.ac.uk.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2016 May 24; Vol. 67 (20), pp. 2375-2377.

Pathophysiology of takotsubo syndrome: temporal phases of cardiovascular responses to extreme stress.

Autor: Wright PT; National Heart and Lung Institute, Imperial College London., Tranter MH, Morley-Smith AC, Lyon AR

Publikováno v: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2014; Vol. 78 (7), pp. 1550-8. Date of Electronic Publication: 2014 Jun 23.

Authors' reply.

Autor: Morley-Smith AC, Omerovic E, Lyon AR

Publikováno v: British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2013 Jul; Vol. 74 (7), pp. 415.